Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelocytic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00854646
What this trial is testing

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelocytic Leukemia+2 more
Traws Pharma, Inc. 22
Early research (Phase 1)Study completedNCT01051063
What this trial is testing

Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Who this might be right for
Leukaemia, Myelocytic, Acute
GlaxoSmithKline 17
Early research (Phase 1)UnknownNCT03796390
What this trial is testing

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

Who this might be right for
Acute Myelocytic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 15
Testing effectiveness (Phase 2)UnknownNCT06105658
What this trial is testing

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

Who this might be right for
Acute Myelocytic Leukemia
Anhui Provincial Hospital 20
Large-scale testing (Phase 3)Study completedNCT01188798
What this trial is testing

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+2 more
St. Jude Children's Research Hospital 6
Testing effectiveness (Phase 2)Ended earlyNCT01050946
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Lymphocytic, ChronicLeukemia, Myelocytic, Acute+3 more
Medical College of Wisconsin 1
Early research (Phase 1)Study completedNCT00251368
What this trial is testing

Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteAcute Lymphocytic Leukemia
Dana-Farber Cancer Institute 52
Early research (Phase 1)Ended earlyNCT00048100
What this trial is testing

Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes

Who this might be right for
Leukemia, Myelocytic, Acute
M.D. Anderson Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT00406393
What this trial is testing

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

Who this might be right for
Leukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Medical College of Wisconsin 304
Large-scale testing (Phase 3)Study completedNCT03106779
What this trial is testing

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 233
Early research (Phase 1)Study completedNCT00502385
What this trial is testing

Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML

Who this might be right for
LeukaemiaMyelocyticAcute
AstraZeneca 54
Testing effectiveness (Phase 2)UnknownNCT03556982
What this trial is testing

CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML）

Who this might be right for
Leukemia, Myeloid, Acute
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Early research (Phase 1)Study completedNCT01607892
What this trial is testing

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Who this might be right for
Hematological Malignancies
Karyopharm Therapeutics Inc 286
Large-scale testing (Phase 3)Study completedNCT04948333
What this trial is testing

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 199
Large-scale testing (Phase 3)Study completedNCT02272777
What this trial is testing

Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

Who this might be right for
Leukemia
Novartis Pharmaceuticals 225
Testing effectiveness (Phase 2)Study completedNCT00201240
What this trial is testing

Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

Who this might be right for
Leukemia, Myelocytic, Acute
National Heart, Lung, and Blood Institute (NHLBI) 47
Testing effectiveness (Phase 2)Study completedNCT00061581
What this trial is testing

Experimental Bone Marrow Transplant Protocol

Who this might be right for
Acute Lymphocytic LeukemiaChronic Myeloid LeukemiaAcute Myelocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07423104
What this trial is testing

Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Rochester 24
Testing effectiveness (Phase 2)Study completedNCT01474681
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Who this might be right for
Acute Myelocytic LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Novartis Pharmaceuticals 27
Not applicableLooking for participantsNCT07061145
What this trial is testing

A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelocytic LeukemiaErectile DysfunctionsCVD - Cardiovascular Disease+1 more
Azienda USL Reggio Emilia - IRCCS 350
Next Page